Abano Healthcare Group Limited provided earnings guidance for the first half of 2017. For the first half, the company expected gross revenue are expected to be $135 to $140 million and revenue is expected to be $113 to $118 million. EBITDA is forecast to be $14.4 to $15.6 million with underlying EBITDA of $14.8 to $16.0 million. Net Profit After Tax is expected to be between $4.5 to $5.1 million, with underlying NPAT between $5.0 to $5.6 million.